Clinical Trial Update: Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of gemcitabine and doxorubicin in patients with recurrent or progressive head and neck cancer; results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-07-12